MedPath

Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence.

Recruiting
Conditions
cervix,cancer,mri, diffusion
Registration Number
NL-OMON23918
Lead Sponsor
niversity Hospitals, KULeuven,Leuven,BelgiumErasmus University Medical Center,Rotterdam,The Netherlands
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

1. Primary cervical cancer;

2. Patients treated with radiation therapy with curative intent, with or without concomitant chemotherapy or hyperthermia;

Exclusion Criteria

1. Pregnancy;

2. Contra-indications for general anesthesia;

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The purpose of this project is to evaluate the sensitivity and specificity of DWI after therapy in the prediction of recurrence of cervical uterine cancer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath